⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17184356 | 0.98 | ALDH1A1 (0.42) | — | |
| Hydrochloric Acid SCHEMBL1028586 | 0.98 | — | — | |
| Acetaldehyde SCHEMBL7630487 | 0.88 | CYP2C19 (0.39) | — | |
| SCHEMBL2170936 | 0.86 | — | — | |
| SCHEMBL8671012 | 0.85 | FDPS (0.47) | — | |
| SCHEMBL8560648 | 0.85 | HRH1 (0.40) | — | |
| Hydrochloric Acid SCHEMBL27275786 | 0.85 | TSHR (0.39) | — | |
| Hydrochloric Acid SCHEMBL17184529 | 0.85 | TSHR (0.39) | — | |
| SCHEMBL627047 | 0.83 | HRH1 (0.43) | — | |
| SCHEMBL69929 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673146-A2 | METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS | Biohaven Therapeutics Ltd. (VG) | 2026-01-07 | — | — | EP | claimed |
| WO-2024182465-A2 | METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS | ALCO THERAPEUTICS, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| US-20160000777-A1 | METHODS OF USING HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF ROCHESTER (US) | 2016-01-07 | — | — | US | claimed |
| EP-2627631-B1 | PYRROLIDINONES AS METAP2 INHIBITORS | MERCK PATENT GMBH (DE) | 2015-12-16 | — | — | EP | claimed |
| WO-2014130759-A1 | METHODS OF USING HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF ROCHESTER (US) | 2014-08-28 | — | — | WO | claimed |
| US-20070086981-A1 | Delivery peptides, their constructs with active agents and use | ORTHOGEN AG (DE) | 2007-04-19 | — | — | US | claimed |
| WO-2007001406-A2 | ARYL-CONTAINING MACROCYCLIC COMPOUNDS | CHIRON CORPORATION (US) | 2007-01-04 | — | — | WO | claimed |
| EP-1694696-A1 | DELIVERY PEPTIDES ,THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE | ORTHOGEN Aktiengesellschaft (DE) | 2006-08-30 | — | — | EP | claimed |
| WO-2005054279-A1 | DELIVERY PEPTIDES, THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE | ORTHOGEN AG (DE) | 2005-06-16 | — | — | WO | claimed |
| US-5116856-A | AMINOETHYLTHIAZOLE AND AMINOETHYLOXAZOLE DERIVATIVES | AKZO N.V. (NL) | 1992-05-26 | — | — | US | claimed |
| EP-0385525-A1 | Aminoethylthiazole and aminoethyloxazole derivatives | Akzo Nobel N.V. (NL) | 1990-09-05 | — | — | EP | claimed |
| US-4474876-A | Flow cytometric analysis of histamine receptors | TRUSTEES OF BOSTON UNIVERSITY (US) | 1984-10-02 | — | — | US | claimed |
| JP-2273664-A | — | — | None | — | — | JP | disclosed |
| US-20260070903-A1 | NOVEL PYRIDO[3,4-D]PYRIMIDIN-8-ONE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING CANCER, COMPRISING SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-12 | — | — | US | disclosed |
| EP-4673146-A2 | METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS | Biohaven Therapeutics Ltd. (VG) | 2026-01-07 | — | — | EP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-0271829-A2 | Delta-hydroxy-beta-lysine derivatives and their production | Takeda Chemical Industries, Ltd. (JP) | 1988-06-22 | — | — | EP | disclosed |
| US-4474876-A | Flow cytometric analysis of histamine receptors | TRUSTEES OF BOSTON UNIVERSITY (US) | 1984-10-02 | — | — | US | disclosed |
| US-4228176-A | ANTIINFLAMMATORY AGENT | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| US-4172139-A | CARDIOVASCULAR DISORDERS | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1979-10-23 | — | — | US | disclosed |